In the first part of our series on GP-led restructurings, KWM's Gabriel Boghossian laid out what should happen at the beginning of the process. Now he takes us through the stages immediately before a deal.
The industry did not want a Trump presidency, but now that it’s a reality, what are the silver linings?
Gabriel Boghossian, who leads secondaries at King and Wood Mallesons, discusses what full disclosure in GP-led deals means and what to watch out for when testing the market.
Campbell Lutyens and 17Capital are the latest firms to boost or establish their presence in New York, so how important is it that secondaries players have an address there?
US head Benoît Verbrugghe may think the global investment manager isn't as exotic as other firms, but there's nothing boring about being the biggest secondaries firm in the market.
GP-led restructurings once sat comfortably in the ‘non-traditional secondaries’ bucket, but the definition is evolving as buyers search for higher returns through even more complex deals.
While secondaries deals are at their core simply trades, buyers have become more specialised, and advisors too have become more selective about the areas they compete in, according to Sixpoint Partners' Shawn Schestag.
SVG’s capitulation to HarbourVest’s final offer for its portfolio marks the end of a saga that may usher in a new era for secondaries.
Recent SEC focus on fund restructuring has put pressure on GPs to make sure their limited partners get fair treatment during the process. Molly Diggins, general counsel for advisory firm Monument, who says LPs should make themselves heard and ask for greater transparency.
As the drama over the London-listed private equity vehicle unfolds, PEI sizes up the dramatis personae.